Skip to main content

Alzheimer’s Disease

Alliance Applauds Medicare Decision to End Restrictions on Access to Alzheimer’s Diagnostics

Alliance Applauds Medicare Decision to End Restrictions on Access to Alzheimer’s Diagnostics

October 13, 2023

Alliance Offers Recommendations to Keep Patients at Center of Payment-Related Decision-Making

Alliance Offers Recommendations to Keep Patients at Center of Payment-Related Decision-Making

September 12, 2023

35 Organizations to CMS: Thank You for Proposal to Discontinue CED on PET Scans

35 Organizations to CMS: Thank You for Proposal to Discontinue CED on PET Scans

August 16, 2023

Alliance Applauds CMS Proposal to Withdraw Requirement Limiting Access to PET Scans

Alliance Applauds CMS Proposal to Withdraw Requirement Limiting Access to PET Scans

July 18, 2023

Hill Briefing Highlights Need, Voters’ Desire for Access to Newly FDA-approved Treatment to Slow Alzheimer’s

Hill Briefing Highlights Need, Voters’ Desire for Access to Newly FDA-approved Treatment to Slow Alzheimer’s

July 14, 2023

Talking About Neuropsychiatric Symptoms of Alzheimer’s Disease

July 11, 2023

Alliance Celebrates the First-Ever, FDA Traditional Approval of a Disease-Modifying Therapy for Early Alzheimer’s

July 6, 2023

Alliance to Peripheral and Central Nervous System Drugs Advisory Committee: Serve as True Advisors to the FDA’s Expert Review

June 9, 2023

Alliance Statement on CMS’ ‘Plan to Ensure Availability of New Alzheimer’s Drugs’

June 1, 2023

Leading organizations ask FDA advisory committee to consider patient needs in Alzheimer’s-delaying treatments

May 25, 2023

New Poll: Huge Majorities Want Medicare to Cover Cost of Alzheimer’s Drugs

May 23, 2023

Important News for Older Adults: FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease

May 11, 2023

Alliance and Partners Urge FDA Advisory Committee to Listen to Perspectives of Alzheimer’s Patients and Families when Considering Expansion of Brexpiprazole Label

April 14, 2023

Alliance Advocates for Equitable Access for Alzheimer’s Patients Seeking New Treatment

March 17, 2023

Alliance Criticizes CMS Decision to Restrict Access to Alzheimer’s Therapies

February 23, 2023

Alliance Report: Medicare Using ‘Coverage with Evidence Development’ to Ration Patient Access to FDA-Approved Treatments

February 13, 2023